 |
|
|
Quick Help |
 |
|
 |
|
Services |
 |
|
 |
|
 |
Queries |
 |
Tel1: +91 79 65123395 |
Tel2: +91 79 26463395 |
Email: click here |
 |
|
 |
 |
 |
|
|
 |
 |
Search Results for: S |
 |
|
 |
|
 |
31 |
(3S)-3-(tert-Butoxycarbonyl)amino-1-chloro-4-phenyl-2-butanone
Manus Aktteva Biopharma LLP offers Saquinavir Intermediate, (3S)-3-(tert-Butoxycarbonyl)amino-1-chloro-4-phenyl-2-butanone, having a cas no 102123-74-0, for your requirements of RND, evaluation, pilots and commercials along with supportive technical ....
View Detail
|
 |
|
|
32 |
(3S,4R)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine
Manus Aktteva Biopharma LLP offers Paroxetine hydrochloride Intermediates,105812-81-5, (3S,4R)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine,for your evaluation,pilots and commercial requirements with supportive technical package required for....
View Detail
|
 |
|
|
33 |
(4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone
Manus Aktteva Biopharma LLP offers 189028-93-1, Ezetimibe Intermediate,for your RND, Pilots and commercial requirements with supportive technical package required for evaluation
View Detail
|
 |
|
|
34 |
(S)-(+)-3-Chloro-1,2-propanediol
Manus Aktteva Biopharma LLP offers Rivaroxaban Intermediate, (S)-(+)-3-Chloro-1,2-propanediol, 60827-45-4,for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
35 |
(S)-(+)-N-(2,3-Epoxypropyl)phthalimide
Manus Aktteva Biopharma LLP offers (S)-(+)-N-(2,3-Epoxypropyl)phthalimide, 161596-47-0, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
36 |
(S)-(-)-1,2,3,4-Tetrahedro-naphthoic acid
Manus Aktteva Biopharma LLP offers Solifenacin Succinate Intermediate,85977-52-2, (S)-(-)-1,2,3,4-Tetrahedro-naphthoic acid, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
37 |
(S)-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine
Manus Aktteva Biopharma LLP offers Duloxetine intermediate, (S)-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine, 132335-44-5, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
38 |
(S)-1,2,3,4-Tetrahydro-5-methoxy-N-propyl-2-naphthalenamine hydrochloride
Manus Aktteva Biopharma LLP offers Rotigotine hydrochloride Intermediate, 93601-86-6, (S)-1,2,3,4-Tetrahydro-5-methoxy-N-propyl-2-naphthalenamine hydrochloride, for your evaluation,pilots and commercial requirements with supportive technical package ....
View Detail
|
 |
|
|
39 |
(S)-1-tert-Butyl 2-ethyl 2,3-dihydro-1H-pyrrole-1,2-dicarboxylate; Ethyl N-Boc-L-proline-4-ene
Manus Aktteva Biopharma LLP offers Saxagliptin Intermediate,(S)-1-tert-Butyl 2-ethyl 2,3-dihydro-1H-pyrrole-1,2-dicarboxylate; Ethyl N-Boc-L-proline-4-ene, 178172-26-4,for your evaluation,pilots and commercial requirements with supportive technical p....
View Detail
|
 |
|
|
40 |
(S)-2-(Aminomethyl)-1-ethylpyrrolidine
Manus Aktteva Biopharma LLP offers Levosulpiride intermediate, 22795-99-9, (S)-2-(Aminomethyl)-1-ethylpyrrolidine, for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation for int....
View Detail
|
 |
|
|
41 |
(S)-2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine
Manus Aktteva Biopharma LLP offers Bepotastine besilate intermediate,201594-84-5, (S)-2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine,for your evaluation,pilots and commercial requirements with supportive technical package required for evaluatio....
View Detail
|
 |
|
|
42 |
(S)-2-Amino-5-methoxytetralin hydrochloride
Manus Aktteva Biopharma LLP offers Rotigotine hydrochloride Intermediate, 58349-17-0, (S)-2-Amino-5-methoxytetralin hydrochloride, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
43 |
(S)-3-Amino-1,2-propanediol
Manus Aktteva Biopharma LLP offers Rivaroxaban Intermediate,(S)-3-Amino-1,2-propanediol, 61278-21-5, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
44 |
(S)-3-Aminoquinuclidine dihydrochloride
Manus Aktteva Biopharma LLP offers 119904-90-4, (S)-3-Aminoquinuclidine dihydrochloride, Solifenacin Succinate Intermediate,for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluatio....
View Detail
|
 |
|
|
45 |
(S)-3-Dimethylamino-1-(3-methoxyphenyl)-2-methyl-1-propanone
Manus Aktteva Biopharma LLP offers Tapentadol Intermediate,850222-40-1, (S)-3-Dimethylamino-1-(3-methoxyphenyl)-2-methyl-1-propanone, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
|
|
|
|
 |
NOTE:
- Manus Aktteva Biopharma LLP, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
- Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
PATENTS:
- => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
=> Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
|
|
|
|
|